A potential therapeutic application of SET/I2PP2A inhibitor OP449 for canine T-cell lymphoma.
Fujiwara N, Kawasaki H, Yabe R, Christensen DJ, Vitek MP, Mizuno T, Sato K, Ohama T.
J Vet Med Sci.